Percutaneous left atrial appendage closure in patients with primary hemostasis disorders and atrial fibrillation-Reference-Cited by-同舟云学术

Percutaneous left atrial appendage closure in patients with primary hemostasis disorders and atrial fibrillation

Published:2021-11-25 Issue: Volume: Page:
ISSN:1383-875X
Container-title:Journal of Interventional Cardiac Electrophysiology
language:en
Short-container-title:J Interv Card Electrophysiol

Author:

Dognin Nicolas^ORCID,Salaun Erwan,Champagne Catherine,Domain Guillaume,O’Hara Gilles,Philippon François,Paradis Jean-Michel,Faroux Laurent,Beaudoin Jonathan,O’Connor Kim,Bernier Mathieu,Rodés-Cabau Josep,Champagne Jean

Publisher

Springer Science and Business Media LLC

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10840-021-01073-0.pdf

Reference45 articles.

1. Lip GYH, Nieuwlaat R, Pisters R, Lane DA, Crijns HJGM. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation. Chest. 2010;137(2):263–72. https://doi.org/10.1378/chest.09-1584.

2. Takashima N, Arima H, Kita Y, Fujii T, Miyamatsu N, Komori M, … Nozaki K. Incidence, management and short-term outcome of stroke in a general population of 1.4 million Japanese- Shiga Stroke Registry. Circ J. 2017; 81 (11):1636–1646. https://doi.org/10.1253/circj.CJ-17-0177

3. Lip GYH, Collet JP, de Caterina R, Fauchier L, Lane DA, Larsen TB, … Scott-Millar R. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE). EP Europace. 2017;19(11):1757–1758. https://doi.org/10.1093/europace/eux240

4. Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, … Sick P. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. 2009;374:9.

5. Holmes DR, Kar S, Price MJ, Whisenant B, Sievert H, Doshi SK, … Reddy VY. Prospective randomized evaluation of the Watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy. J Am Coll Cardiol. 2014;64(1):1–12. https://doi.org/10.1016/j.jacc.2014.04.029

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management strategies and outcomes of thromboembolism prevention in atrial fibrillation co-existing with immune thrombocytopenia: A review of evidence;IJC Heart & Vasculature;2024-10

2. Debates Surrounding the Use of Antithrombotic Therapy in Hemophilic Patients with Cardiovascular Disease: Best Strategies to Minimize Severe Bleeding Risk;International Journal of Molecular Sciences;2024-07-18

3. Percutaneous Left Atrial Appendage Closure in a Patient With Acquired Von Willebrand Disease and Atrial Fibrillation;Cureus;2024-07-06

4. Left atrial appendage closure in a patient with hemophilia C. An option or the only antithrombotic treatment for patients with a rare bleeding disorder?;Kardiologia Polska;2023-08-26

5. How we manage cardiovascular disease in patients with hemophilia;Haematologica;2023-01-26